Navigation Links
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
Date:5/21/2009

participating in the study, ensuring a patient population composed of multiple ethnic groups. The patient and lesion types studied in SPIRIT V include patients with diabetes (30 percent of patients; 794 patients), patients with multi-vessel disease (42 percent of patients; 1,107 patients), patients with highly complex lesions (lesion type B2 or C; 82 percent of lesions; 2,307 patients), patients with moderately or severely calcified lesions (29 percent of lesions; 809 patients), patients with longer lesions (greater than or equal to 20 mm; 28 percent of lesions; 911 patients) that need treatment, and patients with smaller vessels (reference vessel diameter less than or equal to 2.75 mm, 35 percent of lesions, 1,068 patients).* The safety and efficacy of XIENCE V has not been established in the United States for patients with multi-vessel disease, patients with highly complex lesions (lesion type B2 or C), or patients with severely calcified lesions.

The primary endpoint of the study is a composite rate of all death, heart attack (myocardial infarction) and target vessel revascularization at 30 days, in which XIENCE V had a rate of 2.7 percent. At one year, the SPIRIT V study demonstrated the following positive results for XIENCE V:

  • A 1.8 percent rate of repeat procedure to the treated lesion (TLR)
  • A 0.7 percent cumulative rate of definite/probable stent thrombosis (to one year) and a low 0.2 percent rate of definite/probable late stent thrombosis (between 30 days and one year)
  • A 5.1 percent rate of MACE
  • A 1.1 percent rate of cardiac death

All events were adjudicated according to the Academic Research Consortium (ARC) definitions by an independent Clinical Events Committee. The ARC definitions were developed to eliminate variability in definitions across various drug eluting stent trials; using ARC definitions to measu
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
2. Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
3. Spirit II explores long-term performance of XIENCE V stent
4. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
5. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
6. Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
7. Ted Karkus Admits to Financial Relationship With Dr. Richard A. Rosenbloom; Demonstrates Pattern of Improper Influence, Unethical Behavior, Falsification and Distortion; Company Questions What Else Karkus May Be Hiding From Shareholders
8. Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009
9. Concord Coalition Says New Trustees Report Demonstrates the Importance of Health Care Cost Control
10. Ben-Gurion U of the Negev study demonstrates link between appetite and elderly mortality
11. New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 29, 2015 , ... Rio Salado College joined nine ... experience as part of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models ... the third Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which is ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United ... to celebrate children helping children, a thank you to the many creative and ... contributed to the United Methodist initiative to end malaria deaths. , The Columbus ...
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering ... the second year to the Adams County Fairgrounds in Mendon, IL on May 30th, ... money to support music education in the underfunded school districts of Mendon and its ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... As ... from Merz, received FDA clearance for results that last for two years, the ... exciting news for patients who are looking for a long-lasting, effective solution for their ...
(Date:8/28/2015)... ... 2015 , ... Loved ones of a person suffering from ... dependency, may be able to find some hope in the latest video uploads ... addiction located in Western Michigan. Focusing on several different aspects of the powerful ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... The sickle cell trait could be a causealbeit rareof ... during football training, according to a scientific poster ... Cardiology (ACC) Scientific Sessions, April 1-3, in New Orleans. ... 8 percent of African-Americans in the U.S., has been ...
... Fla. A study published in Cancer Discovery, the ... debuting here at the AACR 102nd Annual Meeting 2011, ... in the tumor microenvironment may help researchers better target ... University of California, San Francisco, demonstrated that the level ...
... of a study presented at the AACR 102nd Annual Meeting ... that improving quality of life affects stress-related biological markers and ... that telomeres shorten and deteriorate with aging, but they are ... trying to understand the interconnections between the mind and the ...
... -- Researchers who sequenced the entire genomes of tumors ... mutations, most of which were unique to individual patients. ... predict breast cancer patient outcomes and to find new ... Louis and the Siteman Cancer Center. After sequencing ...
... Highly exciting new data presented today at the ... superior virological response in HCV patients of genotypes ... Pegylated Interferon-alpha (PegIFN-alpha-2a), the current standard of care ... so important because they show PegIFN-lambda could provide ...
... two compounds that inhibit two of the most frequently ... Phase I trial, according to data presented at the ... The research, presented by Johanna Bendell, M.D., ... GDC-0941, which inhibits PI3K. Bendell, director of Gastrointestinal ...
Cached Medicine News:Health News:Young black athletes with sickle cell trait might be susceptible to sudden death 2Health News:Immune system may guide chemotherapy for breast cancer 2Health News:Chronic stress of cancer causes accelerated telomere shortening 2Health News:Most Breast Tumors Have Unique Genetic 'Fingerprint,' Study Finds 2Health News:PegIFN-lambda shows superior virological response and improved safety than PegIFN-alpha-2a 2Health News:Combining MEK and PI3K inhibitors appears encouraging in a safety study with early signs of anti-tumor activity 2
(Date:8/28/2015)... Massachusetts and LONDON , August ... approach seamlessly connects ... continuum improving outcomes and the ...  (NYSE: PHG AEX: PHIA) today announced its presence at  ... latest cardiology solutions, including Heart Model A.I. , EchoNavigator and ...
(Date:8/27/2015)... 27, 2015  A recent study by Feucht ... compared the Arthrosurface HemiCAP® Wave implant, which is ... "onlay" design implant for isolated patellofemoral disease. While ... and pain scores, none of the patients in ... However, 53% of the patients in the "onlay" ...
(Date:8/27/2015)... , Aug. 27, 2015 ieCrowd™ ... in the commercial development of the company,s supplemental ... Smart Oxygen device, being developed by ieCrowd,s subsidiary ... a patient,s changing demand for oxygen based on ... 510 (k) submission for the Smart Oxygen device ...
Breaking Medicine Technology:Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... Israel, August 31, 2011 Elbit Imaging Ltd. ... for the second quarter of 2011. Consolidated revenues ... to NIS 241 million (US$ 71 million) compared to NIS 573 ... decrease is mainly attributable to: (i) we reported non-recurring gain from ...
... EXTON, Pa., Aug. 30, 2011 Kensey Nash Corporation ... at the following investor conferences in September. ... Growth Conference 2011 in Chicago on Wednesday, September 7th, ... company,s website ( www.kenseynash.com ) at 8:00 a.m. ET ...
Cached Medicine Technology:Elbit Imaging Ltd. Announces Second Quarter Results for 2011 2Elbit Imaging Ltd. Announces Second Quarter Results for 2011 3Elbit Imaging Ltd. Announces Second Quarter Results for 2011 4Elbit Imaging Ltd. Announces Second Quarter Results for 2011 5Elbit Imaging Ltd. Announces Second Quarter Results for 2011 6Elbit Imaging Ltd. Announces Second Quarter Results for 2011 7Elbit Imaging Ltd. Announces Second Quarter Results for 2011 8Elbit Imaging Ltd. Announces Second Quarter Results for 2011 9Elbit Imaging Ltd. Announces Second Quarter Results for 2011 10Kensey Nash Investor Conference Schedule 2
... Tecans MiniPrep series of robotic workstations ... The MiniPrep is the ideal automation ... automation of routine laboratory procedures, improving throughput, ... based Gemini for MiniPrep software allows you ...
... QFill2 is the ideal system for fast, accurate ... pressure driven, pinch valve controlled dispensing mechanism, ensures ... all of the components that come into contact ... clean, and autoclave. The unique compact design saves ...
... Automatic dispenser for low volumes. Dispenses ... 1536 -well format. Fast throughput of less ... productivity. The dispenser features an intuitive user ... be used to dispense liquids and suspensions, ...
... low volumes. Dispenses volumes down to 0.5ul ... throughput of less than 30 seconds per ... an intuitive user interface that provides one-button ... liquids and suspensions, beads, or cells, with ...
Medicine Products: